Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study)
| Autor: | Luigi Cavanna, Alessandro Capucci, Massimo F Piepoli, Luigi Tommasi, Francesco Passerini, Daniele Vallisa, Mariacristina Arbasi, Luigi Cerri, Monica Mori, Agostino Rossi |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
Cardiac function curve medicine.medical_specialty medicine.medical_treatment Myocardial Infarction Autonomic Nervous System Cardiography Impedance Ventricular Function Left Catheterization Oxygen Consumption Heart Rate Internal medicine medicine Humans Myocardial infarction Radionuclide Imaging Aged Bone Marrow Transplantation Ultrasonography Tomography Emission-Computed Single-Photon Ejection fraction medicine.diagnostic_test business.industry Percutaneous coronary intervention Stroke Volume Stroke volume Baroreflex Middle Aged medicine.disease Impedance cardiography Treatment Outcome Heart failure Conventional PCI Electrocardiography Ambulatory Exercise Test Cardiology Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | European Journal of Heart Failure. 12:172-180 |
| ISSN: | 1879-0844 1388-9842 |
| Popis: | Aims Bone marrow (BM) stem cells improve cardiac function and outcome after acute ST-segment elevation myocardial infarction (MI). In this randomized controlled trial, the effects of intracoronary transfer of autologous BM cells on left ventricular ejection fraction (LVEF) and volumes (2D-echo and resting SPECT), stroke volume [impedance cardiography (ICG)], autonomic control [heart rate variability (HRV)], baroreflex sensitivity (BRS), and exercise tolerance (cardiopulmonary exercise test) were assessed in post-MI patients. Exercise stress SPECT was also performed. Methods and results After percutaneous coronary intervention (PCI), 38 patients with residual LV dysfunction were randomized to either the BM group (optimized treatment plus intracoronary transfer of autologous BM cells 4 ± 1 days after PCI, n = 19) or control (C) group (optimized treatment only, n = 19). After 12 months, mean LVEF (%) increased 13.1 ± 1.9 in the BM patients vs. 5.3 ± 2.0 in C, with an increase in stroke volume (mL, 14.5 ± 4.0 in BM vs. 1.8 ± 3.7 in C) associated with improved HRV [SD (ms) 62.4 ± 8.3 in BM vs. 19.0 ± 7.5 in C), higher BRS (ms/mmHg, 8.0 ± 1.8 in BM vs. −1.9 ± 1.7 in C), and peak VO2 (mL/kg min−1, 3.5 ± 1.0 in BM vs. −0.4 ± 0.5 in C). Stress SPECT showed improvements in perfusion, regional and global LV function scores (P < 0.05 BM vs. C groups for all comparisons). Cell transfer did not increase the risk of adverse clinical, in-stent restenosis, or proarrhythmic events. Conclusion The beneficial effect of autologous BM cells in post-MI patients with depressed LV function may be mediated by restoration of autonomic control, and improved exercise tolerance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|